These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11313336)

  • 1. Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells.
    Butscher WG; Haggerty CM; Chaudhry S; Gardner K
    J Biol Chem; 2001 Jul; 276(29):27647-56. PubMed ID: 11313336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2.
    Butscher WG; Powers C; Olive M; Vinson C; Gardner K
    J Biol Chem; 1998 Jan; 273(1):552-60. PubMed ID: 9417115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.
    Maggirwar SB; Harhaj EW; Sun SC
    Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
    Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
    Good L; Maggirwar SB; Sun SC
    EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-regulation of T cell growth factor expression by p53 and the Tax oncogene.
    Chaudhry S; Freebern WJ; Smith JL; Butscher WG; Haggerty CM; Gardner K
    J Immunol; 2002 Dec; 169(12):6767-78. PubMed ID: 12471108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional disparity of distinct CD28 response elements toward mitogenic responses.
    Civil A; Rensink I; Aarden LA; Verweij CL
    J Biol Chem; 1999 Nov; 274(48):34369-74. PubMed ID: 10567414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C-theta participates in the activation of cyclic AMP-responsive element-binding protein and its subsequent binding to the -180 site of the IL-2 promoter in normal human T lymphocytes.
    Solomou EE; Juang YT; Tsokos GC
    J Immunol; 2001 May; 166(9):5665-74. PubMed ID: 11313407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity.
    Sánchez-Valdepeñas C; Martín AG; Ramakrishnan P; Wallach D; Fresno M
    J Immunol; 2006 Apr; 176(8):4666-74. PubMed ID: 16585559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
    Nolz JC; Fernandez-Zapico ME; Billadeau DD
    J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclic adenosine 5'-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism.
    Tenbrock K; Juang YT; Tolnay M; Tsokos GC
    J Immunol; 2003 Mar; 170(6):2971-6. PubMed ID: 12626549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.
    Shapiro VS; Truitt KE; Imboden JB; Weiss A
    Mol Cell Biol; 1997 Jul; 17(7):4051-8. PubMed ID: 9199340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes.
    Bannert N; Avots A; Baier M; Serfling E; Kurth R
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1541-6. PubMed ID: 9990060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E; McGuire K; Hedlund G; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production.
    Civil A; Bakker A; Rensink I; Doerre S; Aarden LA; Verweij CL
    J Biol Chem; 1996 Apr; 271(14):8321-7. PubMed ID: 8626528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting combinatorial transcriptional complex assembly at specific modules within the interleukin-2 promoter by the immunosuppressant SB203580.
    Smith JL; Collins I; Chandramouli GV; Butscher WG; Zaitseva E; Freebern WJ; Haggerty CM; Doseeva V; Gardner K
    J Biol Chem; 2003 Oct; 278(42):41034-46. PubMed ID: 12896977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation.
    Yu CT; Shih HM; Lai MZ
    J Immunol; 2001 Jan; 166(1):284-92. PubMed ID: 11123304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.
    Nicot C; Mahieux R; Opavsky R; Cereseto A; Wolff L; Brady JN; Franchini G
    Oncogene; 2000 Apr; 19(17):2155-64. PubMed ID: 10815807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.